Risk of Acute Kidney Injury and Renal Symptoms With Anti-VEGF Agents in RCTs
The following is a summary of “Comparison of Renal Adverse Events Between Intravitreal Anti-Vascular Endothelial Growth Factor Agents: A Meta-Analysis,” published in the December 2024 issue of Ophthalmology by Huang et al. Researchers conducted a retrospective...